Factor Information
Data ID 2528
Factor Risk factor of AIT: BMI<21 (ref=BMI>25)
Description N/A
Biomarker NA
Classification E11 (physiological factor - physical sign)
Association
Application risk assessment and prognosis
Objective Amiodarone-induced thyrotoxicosis (AIT) is a recognized complication of amiodarone treatment with limited management options. Its predisposing factors are incompletely defined yet a higher prevalence was reported in adults with congenital heart disease (CHD). Therefore we sought to determine the incidence and risk factors for AIT in adults with CHD.
p Value <0.0001
OR 11
Conclusion BMI<21 at initiation of amiodarone therapy and presence of goiter are strong predictors of AIT in this population. Its incidence is time dependent. These predictors can be used clinically in assessing overall impact of amiodarone therapy in congenital heart disease patients.
Risk Factor risk factor
CHD Type
ID 148
CHD Type NA
CHD Subtype NA
Reference
PMID 22386642
Year 2013
Title Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease—A cohort study
Sample
Population adults
Source patients' data
Region Rochester, America
Method multivariate cox proportion hazard anlaysis
Race American
Disease History N/A
Treatment History N/A
Group N/A(Treatment) N/A(Control)
Number N/A N/A
Age N/A N/A
Gender (Male: Female) N/A N/A
Marker Level N/A N/A